8/15/2020 · Guizhong Liu, Felix Du, Xiaohong She, Yi Zhu , Anthony W. Tolcher and Peter Luo Cancer Res August 15 2020 (80) (16 Supplement) 4538 DOI:.
12/1/2019 · Anthony Tolcher, Raghad Karim, Christina Rosas, Guizhong Liu, Yi Zhu , Liming Liu, Felix Fangyong Du, Feng Roger Luo and Peter Luo Mol Cancer Ther December 1 2019 (18) (12 Supplement) A082 DOI: 10.1158/1535-7163.TARG-19-A082, View the profiles of professionals named Yi Zhu on LinkedIn. There are 2,700+ professionals named Yi Zhu , who use LinkedIn to exchange information, ideas, and opportunities.
Adagene Inc. Announces Closing of Initial Public Offering and Exercise of Underwriters’ Over-Allotment Option SAN FRANCISCO, Feb. 11, 2021 (GLOBE NEWSWIRE) — Adagene Inc. ( Adagene or the Company) (Nasdaq: ADAG), a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies, today.
3105 Background: ADG106 is a fully human agonistic anti-CD137 monoclonal IgG4 antibody, targeting a unique epitope of CD137 with novel mechanism of actions for CD137 agonism, CD137 ligand antagonism and potent cross-linking via FcgRIIb. This phase 1 study was conducted to assess its safety, tolerability, pharmacokinetic (PK) profile, immunogenicity and preliminary efficacy. Methods: Eligible …
2/27/2018 · Adagene Chinese cancer biotech Adagene (NASDAQ: ADAG) plans to raise $132 million at an $831 million market cap. Its most advanced candidate ADG106 is undergoing Phase 1.
Adagene is a Biotechnology company based at 4F, Building C14, 218 Xinghu St, Suzhou, Jiangsu 215123, CN founded in 2012.
Yi Song, Board Director. Yi Song is the president of Shenzhen Acacia Investment Co.
Ltd. and the Supervisory Director of Shenzhen LEEGSTAR Co.
Ltd. Hongliang Zhu , Board Director. Hongliang Zhu is the chairman of Shenzhen Ready Technology Co.
Ltd.
and the Executive Vice President of Shenzhen Acacia Investment Co.
Ltd. Shibing Chen, Board …
Lizhe Zhu Postdoc Chemistry Department, HKUST: Current Position: … Senior Scientist, Adagene (Suzhou) Limited: Luming Meng Ph.D Chemistry Department, HKUST: Postdoc … Yi Cui: FYP project LIFS, HKUST 2018-2019: Research Assistant Chemistry, HKUST 2020 Current Position: Ph.D Student, The strength of our association is derived from our members. If you are interested in exploring greater opportunities in the biotech and pharmaceutical fields, we encourage you to join us.
